tiprankstipranks
Trending News
More News >

my Portfolio - New Portfolio

ezeinvestor

my Portfolio
Individual Investor
Ranked #324,101 out of 829,561 TipRanks' Investors
Success Rate
49%
45 out of 92
profitable transactions
Average Return
20.54%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 11.32%
6-Month Return▲ 50.39%
12-Month Return▲ 38.29%
YTD Return▲ 38.94%
Total Return▲ 12.77%

Best Trade

Opened at
Closed at-
Gain▲ 435.71%

Bio

Medic

Performance

19.17%0-19.17%
▲ 0.80%
▼ 0.87%
▲ 6.20%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 6.18%
May 2025
▲ 9.25%
▲ 5.14%
▲ 7.90%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 19.17%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 7.36%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 16.40%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 7.68%
Oct 2025
▼ 8.98%
▼ 1.95%
▼ 9.90%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▲ 6.20%
▲ 11.63%▲ 6.28%▲ 6.18%
▲ 9.25%▲ 5.14%▲ 7.90%
▲ 7.60%▲ 2.30%▲ 19.17%
▲ 2.76%▲ 2.05%▲ 7.36%
▲ 12.88%▲ 3.56%▲ 16.40%
▲ 10.96%▲ 2.38%▲ 7.68%
▼ 8.98%▼ 1.95%▼ 9.90%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
CervoMed
0%
▲ 32.05%
1
Open
Nov 04, 2025
Tectonic Therapeutic
0%
▲ 11.70%
1
Open
Oct 30, 2025
SELLAS Life Sciences Group
0%
▼ 25.48%
1
Open
Oct 29, 2025
Precision BioSciences
0%
▼ 38.48%
1
Open
Oct 28, 2025
Rocket Pharmaceuticals
0%
▼ 29.04%
1
Open
Oct 14, 2025
Altimmune
34.24%
▼ 21.50%
3
Buy
Oct 10, 2025
Verona Pharma
▲ 354.85%
3
Close
Oct 06, 2025
Immuneering
0%
▲ 19.27%
1
Open
Oct 06, 2025
Solid Power
0%
▼ 11.61%
1
Open
Oct 06, 2025
MoonLake Immunotherapeutics
22.96%
▲ 55.99%
1
Open
Oct 03, 2025
QuantumScape
0%
▲ 10.21%
4
Open
Sep 23, 2025
Richtech Robotics Inc. Class B
0%
▲ 37.40%
1
Open
Aug 25, 2025
Urogen Pharma
0%
▲ 123.86%
1
Open
Jun 13, 2025
Allogene Therapeutics
▼ 90.21%
2
Close
Mar 27, 2025
Cineverse
▼ 30.37%
6
Close
Mar 27, 2025
Oneok
▲ 343.36%
2
Close
Mar 27, 2025
Paysafe
▼ 91.46%
3
Close
Mar 27, 2025
Trade Desk
▲ 8.49%
2
Close
Mar 27, 2025
Bandwidth
▼ 11.35%
2
Close
Mar 27, 2025
Meta Platforms
▲ 220.72%
2
Close
Mar 27, 2025